We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Biotech Growth Trust (the) Plc | BIOG | London | Ordinary Share |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 1,006.00 | 01:00:00 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 1,006.00 |
| Industry Sector |
|---|
| EQUITY INVESTMENT INSTRUMENTS |
| Top Posts |
|---|
Posted at 16/1/2020 09:56 by its the oxman Discount seems far too large, my thinking is at somepoint investor desire for the fangs will weaken and biotechs with new new breakthroughs underpinned by ever increasing demand from ageing populations etc could easily take over. Not a bad area to have some exposure to regardless. |
Posted at 11/6/2015 11:50 by affemoose Ooops, meant the post the below in case you do not know already. Sorry about above rant!!Geoffrey Hsu of OrbiMed Capital LLC, the Portfolio Manager of The Biotech Growth Trust PLC, will be presenting to investors and shareholders in London on Wednesday, 8 July 2015. BIOG has performed exceptionally well over a sustained period, significantly outperforming both the FTSE All-Share benchmark and the NASDAQ Biotechnology Index over 1, 3 and 5 years. OrbiMed is the world's largest specialist healthcare fund manager with over $15bn invested worldwide. Geoffrey Hsu will provide an update on the biotech sector and the factors determining future growth. The presentation will start soon after 12.15pm, immediately after the conclusion of the ordinary business of the AGM, which commences at 12 noon. More information on The Biotech Growth Trust PLC can be found at www.biotechgt.com. Details are as follows: BIOG AGM and Investor Presentation: Date: Wednesday 8th July Time: 12 noon – AGM 12:15 – Investor Presentation 13:30 – Buffet Lunch Venue: Barber Surgeons' Hall, Monkwell Square, London EC2Y 5BD Please RSVP to info@frostrow.com if you are able to join us, as places are limited. |
Posted at 01/11/2014 19:53 by rford78 There is an alternative outstanding biotech trust, BB Biotech, (ticker BION on Swiss SWX/ISIN CH0038389992 and certain European exchanges) which has been vastly outperforming BIOG year to date , operates buybacks and pays a 3.5% annual dividend, trading at over a 20% discount. I believe its overall annual fees are slightly lower than BIOG. Investors need to access this trust via brokerage accounts which permit trading in overseas/European markets. |
Posted at 05/6/2014 19:41 by philo124 Just reading Annual Report and Accounts- impressed."Your Board believes that the long term investor in the biotechnology sector will continue to be well rewarded." fwiw, I agree. |
Posted at 14/7/2013 10:53 by protean The sector is on a roll:dealbook.nytimes.com |
Posted at 02/4/2012 20:28 by 4wingrove Private investors will be looking into buying into this as it appears as a top performer over 3 years in quite a few publications |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
